Veterinary pain management market accounted for a market value of US$ 1,078.5 Mn in 2017 and projected to grow at a CAGR of 7.9% during the forecast period from 2018 to 2026. Rising humanization of animals due to developing trend of nuclear family, continuous development in the research & development activities related to the veterinary pain management, and scheduled diagnostics sessions for livestock to maintain the quality of the meat, milk and other products. Improper feeding and unorganized health management of pets & livestock animals leads to obesity and finally leading to joint pain and other disorders. In addition to that, pet and livestock owners are also being counselled & trained by non-government organizations or veterinary doctors to manage health of animals.
A veterinary active pharmaceutical ingredient (API) is any chemical substance in a pharmaceutical drug that produces any desired effect in the animals. Veterinary APIs can be a combination of two or more substances in a drug intended to provide some pharmacological effect.
Tissue expanders are the devices that harness the ability of the organ including skin or other tissues to expand naturally under physiologic pressure such as stretching. Tissue expanders are utilized in the development, or expansion specifically, of skin, and other organs such as breasts, head, and neck among others. Adoption of tissue expansion technique has numerous benefits over biological implants such as rejection of implant by the body can be avoided.
The subcutaneous immunoglobulin are the biologic molecules that are injected subcutaneously for the cure of certain diseases/disorders such as infectious diseases, immune deficiencies, and bleeding disorders among others.
Cervical spondylotic myelopathy occurs due to the progressive degeneration of the spine. The symptoms associated with CSM are radiculopathy, myelopathy, and neck pain syndrome. Spinal laminoplasty is a minimally invasive surgical procedure performed to relieve the excessive pressure created in the spinal cord due to its compression against the wall of the spinal canal.
Respiratory Syncytial Virus (RSV) is a single-stranded RNA virus that causes respiratory infections such as pneumonia, bronchiolitis and among others. In tropical climates, RSV infection is more prominent during the rainy season. RSV infections cause a considerable burden on the global economy due to the high infection rate. According to the Centers for Disease Control and Prevention, an approximate of 150,000 hospitalizations (on average) are a result of RSV infections each year in the United States.
A variety of life-threatening & chronic disorders such as hematological diseases, immune deficiencies, genetic diseases, neurological disorders among others are treated with plasma proteins. The different clinical responses of plasma proteins are due to its unique biochemical profile, and variances in production & processing technologies. Recent developments observed in plasma protein therapeutics industry are satisfactory and ground breaking, especially recently approved recombinant protein therapeutics which caters several clinical indications such as autoimmune diseases, cancers, infectious diseases and genetic disorders.
The pharmaceutical excipients market expected to reach US$ 11,938.1 Mn by 2026 from US$ 6,615.7 Mn in 2017 projecting a steady growth at a compound annual growth rate (CAGR) of 6.87% during the forecast period from 2018 to 2026.
Parkinson’s disease (PD), is progressive nervous system disorders, characterized by tremor, rigidity, bradykinesia, and postural instability. It is estimated that, the global Parkinson’s disease therapeutics market will show significant market growth over the forecast period from 2018 to 2026. Some key factors that drive PD therapeutics market growth are large unmet needs, projected launch of prominent pipeline drugs (APL-130277, Accordion Pill, P2B-001, ND0612H etc.), increase in research and development activities for development of novel PD therapeutics and growing incidence of PD.
The nutrigenomics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 portraying excellent growth with a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026. According to the statistics provided by World Health Organization (WHO), by 2020 chronic diseases will be responsible for 73% of the total global deaths associated with obesity, diabetes, cardiovascular complications and cancer.
Similar to the conventional prosthetics, neural prosthesis or neuroprosthesis are devices that restore or replace the function or a damaged part of the nervous system. Some of such neuroprostheses such as cochlear implant restore the sensory input with simulation to the nervous system. Retinal implant is another breakthrough sensory neuroprosthesis.
Enhancing the viability of preclinical expectations human drugs reactions is critical to reducing expensive failures in clinical trials. The pharmaceutical industry is confronting phenomenal challenges attributable to increasing expenses and the declining efficiency of drug research and development. Late advances in microfabrication, cell biology and microfluidics has empowered the improvement of micro-engineered models of the useful parts of human body known as the organ on chip.
Chagas disease or American trypanosomiasis, is inflammatory disease caused by protozoan parasite Trypanosoma cruzi. It is characterized by inflammation of tissue, mostly of the heart and intestinal tract. According to the World Health Organization (WHO), about 8 million people are infected with chagas disease around the globe, predominantly in Latin America.
The global high throughput screening (HTS) market is growing effectively, valued at US$ 13.2 Bn in 2017 and estimated to reach US$ 24.4 Bn by 2026. Increasing need for drug discovery in pharmaceuticals & biotechnology will enhance the overall expansion of high throughput screening market globally.
The International Society on Thrombosis and Hemostasis 2017 report has stated the global incidence rate of venous thromboembolism to be 2 per 1000 persons. The risk factors associated with venous thromboembolism are prolonged hospital stay, cancer chemotherapy, smoking, alcohol consumption and pregnancy. Heparin has excellent plasma protein binding properties. It has been found to be effective in treatment of Parkinson’s disease via the cathepsin-d activity.
According to WHO study, until now around 70 million people are infected with HIV virus and 35 million died of HIV infection. With rising mortality, the government and non-government institutes are taking initiatives and providing funding for diagnostic treatment and prevention of HIV/AIDS.
The global immunocytokines market is growing significantly. In recent years monoclonal antibodies are being utilized to treat a wide array of cancer-related diseases. These monoclonal antibodies are mainly mono-specific encompassing similar immune cells which are copies of a single parent cell and are concentrated towards a definite cellular target.
The global in-vitro diagnostics quality control market was valued at US$ 854.0 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026. In-vitro diagnostics quality control are tests to validate the efficacy and reliability of the in-vitro diagnostic systems and ensure its accuracy and evaluate the impact of environmental conditions and other things that can affect the test results. Erroneous in-vitro diagnostic testing systems have significant side-effects on the patients.
X-ray inspection systems are automated systems that use X-rays as a source to inspect defects and other inconsistencies in products during quality control and risk management processes. Thus, X-ray inspection, a non-contact imaging technique has garnered lot of interest among manufacturers as one of the promising non-destructive testing (NDT) techniques. These systems that use advanced pattern recognition and image processing software are quickly becoming an integral part of manufacturing processes.
Wilson’s disease occurs equally in both male and female population, but research studies have cited differences in the sex specific phenotypes. Hepatic symptoms occurs 55%-60% more in the female population.
The global pharmaceuticals market has been consistent of large companies based in US and Europe. The pharma market is a challenging one and is constantly evolving to meeting the healthcare needs of a growing population. While generic drugs have dominated the market in developing countries the demand for the latest drug discoveries and better healthcare is increasing demand in these countries. The pharmaceutical industry has seen high level of mergers and acquisition which are helping it grow in a rationalized fashion.
Our reports help identify key industry statistics and trends. Brisk Insights focuses on important performance geographies and competitive analysis.